A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer (Q46916475)
Jump to navigation
Jump to search
scientific article published on 5 November 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer |
scientific article published on 5 November 2007 |
Statements
1 reference
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer (English)
1 reference
A Goncalves
1 reference
M Fabbro
1 reference
C Lhommé
1 reference
L Gladieff
1 reference
J-M Extra
1 reference
A Floquet
1 reference
L Chaigneau
1 reference
A Tisseron Carrasco
1 reference
P Viens
1 reference
5 November 2007
1 reference
1 reference
108
1 reference
1
1 reference
42-46
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference